Life sciences technology leaders largely see themselves as innovators or fast followers, adopting new tools once proven or leading selectively where the business case is clear. Companies in the sector have moved beyond experimentation and into broad adoption of core technologies such as AI, data analytics and cybersecurity. However, while digital investment is widespread, value realisation remains constrained.
Read KPMG’s Global tech report 2026: life sciences report (PDF 545KB) to explore more insights and KPMG life sciences technology specialist perspectives on the findings, and to obtain actionable recommendations for addressing life sciences organisation technology challenges.
Key findings from our research
What life sciences technology function leaders are saying:
About KPMG's global tech
report for life sciences
The insights in this report were derived from the KPMG Global Tech Report 2026, a survey of 2,500 technology leaders from 27 countries across eight industries, including life sciences.
Survey respondents represented organisations with annual operating budgets or revenues above US$100 million and included a diverse group of technology leaders, such as chief data or digital officers, CIOs, CTOs, CISOs, chief AI officers and others.
The life sciences insights are based on the views of 124 life sciences technology function leaders.
Download report
By downloading Global tech report 2026: Life sciences, you will:
- Learn where life sciences companies are really winning with technology – and where they aren’t
- Explore the value capture gap and practical guidance on how to close it
- Gain executive-ready insights that help to support sharper decision-making on where to invest, scale or stop
KPMG Global tech report 2026: Life sciences
A snapshot on technology adoption, investment, and value realisation
Connect with us
- Tim Plenderleith
- Toni Jones
- Tim Robinson
